Krensavage Asset Management
Latest statistics and disclosures from Krensavage Asset Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are BIIB, UTHR, REGN, ALKS, ENTA, and represent 62.18% of Krensavage Asset Management's stock portfolio.
- Added to shares of these 10 stocks: BIIB (+$18M), CAH (+$11M), EXEL, VNDA, REGN, ALKS, EMBC, TARO, EGRX, NXTC.
- Started 1 new stock positions in VNDA.
- Reduced shares in these 5 stocks: MCK (-$17M), ENTA, KOD, UTHR, ASMB.
- Sold out of its positions in ASMB.
- Krensavage Asset Management was a net buyer of stock by $17M.
- Krensavage Asset Management has $314M in assets under management (AUM), dropping by 3.82%.
- Central Index Key (CIK): 0001609251
Tip: Access up to 7 years of quarterly data
Positions held by Krensavage Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Krensavage Asset Management
Krensavage Asset Management holds 14 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Biogen Idec (BIIB) | 15.7 | $49M | +57% | 185k | 267.00 | |
| United Therapeutics Corporation (UTHR) | 13.4 | $42M | 200k | 209.38 | ||
| Regeneron Pharmaceuticals (REGN) | 13.4 | $42M | 61k | 688.88 | ||
| Alkermes (ALKS) | 10.0 | $32M | 1.4M | 22.33 | ||
| Enanta Pharmaceuticals (ENTA) | 9.7 | $31M | -5% | 589k | 51.87 | |
| Embecta Corporation (EMBC) | 9.4 | $30M | 1.0M | 28.79 | ||
| Exelixis (EXEL) | 9.1 | $29M | +20% | 1.8M | 15.68 | |
| Cardinal Health (CAH) | 7.1 | $23M | +88% | 337k | 66.68 | |
| Taro Pharmaceutical Industries (TARO) | 5.5 | $17M | 581k | 29.98 | ||
| McKesson Corporation (MCK) | 3.5 | $11M | -61% | 32k | 339.86 | |
| Kodiak Sciences (KOD) | 1.2 | $3.6M | -15% | 469k | 7.74 | |
| Eagle Pharmaceuticals (EGRX) | 1.0 | $3.2M | 121k | 26.42 | ||
| Vanda Pharmaceuticals (VNDA) | 1.0 | $3.1M | NEW | 312k | 9.88 | |
| Nextcure (NXTC) | 0.0 | $86k | 31k | 2.75 | ||
Setup an alertKrensavage Asset Management will file the next quarterly 13-HR in about 3 months. Would you like to be notified? |
||||||
Past Filings by Krensavage Asset Management
SEC 13F filings are viewable for Krensavage Asset Management going back to 2014
- Krensavage Asset Management 2022 Q3 filed Nov. 15, 2022
- Krensavage Asset Management 2022 Q2 filed Aug. 16, 2022
- Krensavage Asset Management 2022 Q1 filed May 17, 2022
- Krensavage Asset Management 2021 Q4 filed Feb. 15, 2022
- Krensavage Asset Management 2021 Q3 filed Nov. 16, 2021
- Krensavage Asset Management 2021 Q2 filed Aug. 13, 2021
- Krensavage Asset Management 2021 Q1 filed May 18, 2021
- Krensavage Asset Management 2020 Q4 filed Feb. 17, 2021
- Krensavage Asset Management 2020 Q3 restated filed Dec. 8, 2020
- Krensavage Asset Management 2020 Q3 filed Nov. 17, 2020
- Krensavage Asset Management 2020 Q2 restated filed Aug. 20, 2020
- Krensavage Asset Management 2020 Q2 filed Aug. 17, 2020
- Krensavage Asset Management 2020 Q1 filed May 18, 2020
- Krensavage Asset Management 2019 Q4 filed Feb. 18, 2020
- Krensavage Asset Management 2019 Q3 filed Nov. 15, 2019
- Krensavage Asset Management 2019 Q2 filed Aug. 14, 2019